By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market Thursday that its revenues for the third quarter increased 11 percent, with strong growth coming from both its Human Health and Environmental Health divisions.

In the three months ended Oct. 3, the company posted revenues of $419.1 million, up from $377 million in the year-ago period. The results easily beat analysts' consensus estimate for revenues of $401.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: new gene linked to ocular coloboma, new statistical model for interrogating gene expression networks, and more.

With a new collection, PLOS highlights negative results it has published.

A pair of researchers examines political leanings and views on genomics, finding more of a role for optimism and pessimism in people's views.

The genome of the carnivorous bladderwort is smaller than many other plant genomes, but it still holds on to important genes.